WO2018147718A2 - Compositions de péricarpe de cacao et procédé de production de celles-ci - Google Patents
Compositions de péricarpe de cacao et procédé de production de celles-ci Download PDFInfo
- Publication number
- WO2018147718A2 WO2018147718A2 PCT/MX2018/000012 MX2018000012W WO2018147718A2 WO 2018147718 A2 WO2018147718 A2 WO 2018147718A2 MX 2018000012 W MX2018000012 W MX 2018000012W WO 2018147718 A2 WO2018147718 A2 WO 2018147718A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flour
- composition
- pericarp
- cocoa
- food
- Prior art date
Links
- 235000009470 Theobroma cacao Nutrition 0.000 title claims abstract description 76
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 238000004519 manufacturing process Methods 0.000 title description 14
- 244000240602 cacao Species 0.000 title 1
- 235000013312 flour Nutrition 0.000 claims abstract description 83
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 81
- 238000000034 method Methods 0.000 claims abstract description 80
- 238000001035 drying Methods 0.000 claims abstract description 41
- 235000013305 food Nutrition 0.000 claims abstract description 29
- 239000004615 ingredient Substances 0.000 claims abstract description 19
- 210000004369 blood Anatomy 0.000 claims abstract description 18
- 239000008280 blood Substances 0.000 claims abstract description 18
- 238000011282 treatment Methods 0.000 claims abstract description 16
- 239000002537 cosmetic Substances 0.000 claims abstract description 14
- 150000003626 triacylglycerols Chemical class 0.000 claims abstract description 5
- 238000011200 topical administration Methods 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 48
- 230000003078 antioxidant effect Effects 0.000 claims description 25
- 235000013824 polyphenols Nutrition 0.000 claims description 21
- 239000003963 antioxidant agent Substances 0.000 claims description 17
- 235000006708 antioxidants Nutrition 0.000 claims description 17
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 16
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 13
- 229930003935 flavonoid Natural products 0.000 claims description 13
- 235000017173 flavonoids Nutrition 0.000 claims description 13
- 150000002215 flavonoids Chemical class 0.000 claims description 13
- 239000013589 supplement Substances 0.000 claims description 13
- 230000000699 topical effect Effects 0.000 claims description 13
- 241000282412 Homo Species 0.000 claims description 12
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 12
- 235000013361 beverage Nutrition 0.000 claims description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 210000003205 muscle Anatomy 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 6
- 229930013783 (-)-epicatechin Natural products 0.000 claims description 6
- 235000007355 (-)-epicatechin Nutrition 0.000 claims description 6
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000010903 husk Substances 0.000 claims description 4
- 235000015927 pasta Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 230000003020 moisturizing effect Effects 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000013256 coordination polymer Substances 0.000 claims 12
- 125000005456 glyceride group Chemical group 0.000 claims 2
- 235000015432 dried pasta Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 15
- 230000037303 wrinkles Effects 0.000 abstract description 13
- 238000004108 freeze drying Methods 0.000 abstract description 12
- 241001465754 Metazoa Species 0.000 abstract description 7
- 238000010438 heat treatment Methods 0.000 abstract description 6
- 230000000975 bioactive effect Effects 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 206010040829 Skin discolouration Diseases 0.000 abstract 1
- 238000011872 anthropometric measurement Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 231100000257 skin discolouration Toxicity 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 239000002699 waste material Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 description 18
- 239000000902 placebo Substances 0.000 description 14
- 229940068196 placebo Drugs 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 235000015872 dietary supplement Nutrition 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 235000012041 food component Nutrition 0.000 description 12
- 235000014510 cooky Nutrition 0.000 description 11
- 239000005417 food ingredient Substances 0.000 description 11
- 210000003516 pericardium Anatomy 0.000 description 11
- 239000011257 shell material Substances 0.000 description 11
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 8
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 5
- -1 astringent Substances 0.000 description 5
- 235000015895 biscuits Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229940100611 topical cream Drugs 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000000205 acacia gum Substances 0.000 description 4
- 235000010489 acacia gum Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 229940074391 gallic acid Drugs 0.000 description 4
- 235000004515 gallic acid Nutrition 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 241000219161 Theobroma Species 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013322 soy milk Nutrition 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- ZMBWDDDYLYNBHS-UHFFFAOYSA-N acetic acid;propan-2-one;hydrate Chemical compound O.CC(C)=O.CC(O)=O ZMBWDDDYLYNBHS-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229940119429 cocoa extract Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C4/00—Crushing or disintegrating by roller mills
Definitions
- the invention relates to economically advantageous uses of the pericarp of the Theobroma cacao plant pod and edible products and compositions derived from this material.
- the pericarp of the cocoa pod is typically a residual product in the production of cocoa beans and the methods described here make use of what would once be discarded cocoa material.
- the invention employs the pericarp of the sheath and its commercial use in the production of a dietary supplement or food ingredient.
- the pericarp material can be used to make a topical cosmetic composition, and in an example a topical cream, which can deal with coloration, wrinkles, and fine lines on the skin, and another skin condition.
- Theobroma cacao pericarp is an agricultural byproduct generated in abundance in plantations and farms when mature cocoa beans or seeds are removed in the pod processing.
- the term CP is used here because it is a specific term defined in plant biology and refers to the outer tissues of the cocoa pod.
- Cuatrecasas, J., cocoa and Its Allies A Taxonomic Review of the Genus Theobroma, Contributions from the United States National Herbarium (Washington DC) 35, part 6. 1964.
- the pericardium surrounds the cocoa bean and the pulp of the surrounding seed .
- cocoa shell the cocoa shell, and the cocoa pod
- cocoa shell the cocoa shell
- cocoa pod the cocoa pod
- these terms are confusing and frequently used to refer to cocoa bean structures, such as the shell of the seed.
- the seed cover is part of the whole cocoa beans that have typically been fermented and dried. This seed material is not the pericardium. Seed material can often be referred to as a shell, cocoa bean shell, pod, shell or cover material in the scientific literature and in patent documents.
- the cover of the seed is removed from the grain of the seed either before or after roasting grain and before starting the manufacture of chocolate. Therefore, to avoid confusion, the term CP (pericarp of Theobroma cacao) in this invention.
- CP is a main residual product of cocoa bean production on farms or plantations, and therefore for the cocoa bean production industry (Yapo, BM et al. Adding valué to cocoa pod husks as a potential antioxidant -dietary fiber source. Ana. J. Food Nutr. 1, 38-46. 2013 Karim et al., Phenolic composition, antioxidant, anti-wrinkles and tyrosinase inhibitory activities of cocoa pod extract.
- CP cocoa pericardium
- the total phenolic content of the cocoa pod shell sheath is 46.4 ⁇ 0.04 mg of gallic acid equivalents / g, which shows that it is a rich source of phenolic compounds that could be used instead of being discarded (Karim et al., 2014).
- the invention addresses these deficiencies and provides compositions produced from the CP material that can be used in human and animal consumption.
- the methods of the invention can be used to produce a food supplement or a food ingredient which, when consumed regularly, advantageously leads to a dramatic reduction of blood triglyceride levels, and a beneficial improvement in both LDL and HDL levels.
- methods to treat subjects with the CP dietary supplement or ingredient results in weight loss and improvements in muscle strength.
- the CP material is used to make a topical cosmetic composition or a topical cream that can be used to treat discoloration, wrinkles, fine lines or other skin conditions.
- the invention provides a new source rich in beneficial cocoa-derived compounds, such as antioxidants, polyphenols, and flavonoids.
- this invention provides methods for treating humans and animals to improve the levels of various blood markers associated with diseases and / or improved health.
- the invention encompasses commercially advantageous methods for producing a food supplement, ingredient, or functional food made at least in part from the pericarp material of the cocoa pod.
- the "pericarp" is distinguished by three layers: the exocarp or outer skin of the sheath; the thick white mesocarp just below the exocarp; and a thin translucent inner layer called endocarp (see Figure 1).
- pericardium Collectively these layers comprise the outer part of the fruit or pod of cocoa and collectively are referred to as pericardium. Cocoa beans or seeds and the outer layer or membrane surrounding the seeds is different from the pericardium. The seeds or grains are also surrounded in the pod by a mucilaginous pulp material, which, again, is different from the pericardium.
- Cocoa nuggets the part of the seeds used in making chocolate, are surrounded by the cocoa shell, and the cocoa nuggets and shell are not part of the pericarp.
- the invention includes a method for the preparation of a "flour" food composition ingredient of the CP.
- the method comprises isolating the pericardium material from the cocoa pods, where the pericardium material is free of cocoa beans and pulp, forming a paste and drying the pericardium paste, and then crushing the dry material into a type product. flour or processing it in another food ingredient, such as a powder, paste, or extract.
- the method employs a freeze-drying step under vacuum pressure until the pericardium material has a humidity level of 10% or less, 8% or less.
- the method employs a microwave drying step until the pericardium material has a humidity level of 10% or less, or 8% or less, or 5% or less.
- the pericarp material can be milled to obtain a pericarp meal with a particle size of less than 0.500 mm, or less than 0.425 mm.
- the invention may include the measurement of the polyphenol content, the total flavonoid content, and / or the antioxidant capacity of the pericarp material or the flour or food ingredient composition. In this way, the invention allows the production of compositions and the monitoring of advantageously high beneficial levels of flavonoids and polyphenol is derived from cocoa in those compositions.
- the invention encompasses methods for improving the anti-oxidation capacity of the cocoa bean shell material comprising the isolation of the pericarp material from the cocoa pods after harvesting the cocoa beans from the pods of such so that the pericarp material is substantially free of cocoa beans and pulp material, then dry the pericarp material at a humidity level of 10% or less, or 8% or less.
- the dried material is then crushed to form a flour composition or other food ingredient.
- the drying method can be selected from one or more of vacuum freeze drying, oven heating, and microwave treatment.
- the methods may further comprise measuring the activity of the polyphenol oxidase of the pericarp material or of the flour composition or the food ingredient.
- the invention includes prophylactic methods and methods for treating a human subject and / or animals by providing a CP ingredient derived only from the pericarp of the sheath, and administering the ingredient daily or multiple times per day.
- the severely optimally delivered amount will include sufficient of the pericarp-derived cocoa composition to deliver approximately 12.5 mg of the equivalent measured total cocoa flavonoids of (-) -epicatechin per dose.
- Other amounts, doses and administration regimens can also be used and adopted.
- the antioxidant capacity of cocoa-derived material improves the physiological markers associated with certain disease conditions.
- one of the following markers or measurements can be used: triglyceride levels; LDL levels; glucose levels, ratio of LDL / HDL, body mass index; muscle mass; or triglyceride / HDL ratio. Accordingly, daily treatments with beneficial cocoa-derived compounds, or cocoa pod shell pericarp flour described herein, can advantageously improve health or prevent disease.
- the methods for preparing ingredients and compositions may result in a flour-like composition, a paste, and / or an extract of CP.
- Various extraction methods are known in the art and may include the use of chemicals and solvents approved for food.
- Administration of the ingredients or compositions can be done with any suitable carrier, in solid or liquid form such as tablets, capsules, powders, soft gels, solutions, suspensions, emulsions, ointments, or creams.
- the ingredient or composition can also be administered as a food supplement or as a functional food ingredient.
- An extract of the pericarp or flour material can be used alone or in combination with one or more other plant extracts to produce a composition optimized for a particular functional effect.
- an extract composition can be formulated with one or more other dietary nutrients, such as vitamins, minerals, amino acids, etc., to provide a functional or nutritional supplement for the desired health effect.
- these ingredients may be combined with necessary binders, excipients, preservatives, colors and the like known in the industry or commonly used or described in similar products in order to produce a tablet, capsule, pill, liquid, cream, powder, or suitable food ingredient. As indicated, some of its ingredients or compositions can also be used for topical treatments or used in cosmetic products.
- the CP flour composition can be used in a topical cosmetic composition, and in a Example a topical cream.
- the various CP compositions described herein may be mixed with a cosmetically acceptable carrier, which may include purified water, oils, alcohols, glycols, other cosmetically acceptable components available, and combinations thereof.
- Topical cosmetic compositions and methods for using them employ CP flour present in a range of about 0.1% to 1% by weight, or 0.05% to 1% by weight, or 0.05% to 5% by weight, for example.
- the topical cosmetic composition may also include additional ingredients such as penetration enhancers, humectants, lubricants, pharmaceutically active agents, color agents, fragrances, preservatives, antioxidants, chelators, neutralizers, amino acids, anti-inflammatory agents, anti-inflammatory agents.
- additional ingredients such as penetration enhancers, humectants, lubricants, pharmaceutically active agents, color agents, fragrances, preservatives, antioxidants, chelators, neutralizers, amino acids, anti-inflammatory agents, anti-inflammatory agents.
- irritants irritants, anti-adhesive agents, astringent, binders, catalysts, stabilizers, emollients, emulsifiers, surfactants, cell signaling agents, retinols, essential oils, plant / botanical extracts, conditioners, film formers, gel-forming agents, agents foaming agents, scrubs, vitamins, minerals, pH adjusters, proteins, peptides, tactile enhancers, saccharides, solvents or any combination thereof.
- topical skin care composition can be formulated as a cream, lotion, serum, facial cleanser, tonic, eye cream. sun block, bar, spray, impregnated personal care device, impregnated wipes, gel, fluid / liquid, soap, oil, butter, scrubber, cleanser, mask, concentrate, or any other form known in the art.
- the present invention includes a topical skin care composition
- a topical skin care composition comprising a CP flour composition and a cosmetically acceptable carrier together with one more of the following: (a) a source of bio-retinol (b) a Retinol-like activity source; (c) a source of sodium hyaluronic acid or other cosmetically active acid; (d) a source of a moisturizing saccharide complex; (e) a source of ascorbic acid; and (f) a source of antioxidant components.
- a topical cosmetic composition according to the principles of the invention or the following examples applies to the skin, such as to the hands or face, which may have, for example, but is not limited to wrinkles. , fine lines, an uneven tone, loss of firmness, rough surface, dark circuits, boleas under the eyes, sun damage, redness, dryness, irritation, elongated ports and combinations of all or some of the above.
- the topical cosmetic composition can be applied to the skin to prevent the occurrence of several of the problems described above.
- the invention includes methods for the treatment and prevention of skin conditions. using a CP flour composition in a cosmetically acceptable carrier. Such methods include the daily use of the topical cosmetic composition on the skin, and the use of multiple times during a day, for a period of time such as four weeks or more.
- Figure 1 is a top view of a cross-sectional image of a Theobroma of cocoa pod showing the layers of plant matter and the relative vexation of the seeds, the exocarp, mesocarp, and endocarp (Cuatrecasas, J. 1964).
- the "pericarp” is distinguished by three layers; the exocarp or outer skin; the thick white mesocarp just below the exocarp; and a thin translucent inner layer called the endocarp. Collectively these layers comprise the outer part of the fruit and are of maternal origin. These seeds are surrounded by mucilaginous pulp material, and both the seeds and the pulp are not part of the pericarp.
- Figure 2 is a schematic showing a side cross-sectional view of a cocoa pod Theobroma that It lists the location of the seeds, exocarp, mesocarp, and endocarp.
- FIG 3 shows the total phenolic content (TPC) and the total flavonoid content (TFC) of fresh and dried CP flour prepared by different methods: OHD - oven-dried heat ; MWD - microwave dried; and FD-freeze drying.
- the total phenolic content is expressed as mg of gallic acid equivalent / 100 g of dry sample mass (DM) and the total flavonoid content is expressed as mg of equivalent of (-) -epicatechin / 100 g dry sample mass.
- the levels in the graphs with different letters are statistically significant (p ⁇ 0.05).
- Figure 4 shows the changes in grip strength after eight weeks of placebo use or experimental cookie treatment (cookies) (placebo cookies and cookies containing CP flour). There is a positive and significant increase in strength with the regular treatment of CP flour.
- Figure 5 illustrates an example of the wrinkles observed on the back of a volunteer's hand before the application of the CP-based skin cream and after four weeks of local application.
- Figure 6 summarizes the changes observed in the total height of wrinkles on the back of the hand observed in subjects exposed to four weeks of either a placebo or a skin cream based on CP. As you can tell A statistically significant reduction in the total height of wrinkles is noted in subjects treated with PC.
- Figure 7 summarizes the observed changes in the color of the back of the hand noted in subjects exposed to four weeks of either a placebo or a CP-based skin cream. As can be seen, a statistically significant reduction in the color of the back of the hand is observed in subjects treated with PC.
- the invention in one aspect generally encompasses a method of producing and using a food ingredient of specific parts of the CP material.
- the ingredient which can be formed as a flour for baking or food manufacturing, can be used to produce edible products and that promotes health, such as wafers, baked cookies, pastelee, and similar products.
- the ingredient can also be used as a supplement to be added to other food products or as a dietary supplement in the form of a pill or formulated.
- the preferred way to use the pericarp material is a flour-like composition that is capable of being used with a food ingredient or in a food product, such as a baked food.
- the invention is not limited to this preferred form or use.
- the compositions or extracts of the CP material of the invention can also be used as a nutritional supplement.
- the compositions can be introduced in a base carrier or on a carrier.
- the nutritional supplement can be included in a capsule, typically a water soluble capsule, but could be dispersible in water, thus releasing the nutritional supplement once it is mixed with water.
- a capsule could also comprise one or more of a gum, such as acacia gum and gum arabic, methylcellulose gum, dextrin, gelatin, caffeine, milk powder, skim milk powder, soy protein, vegetable protein, or other protein .
- the food supplement may be carried in a granular, flake or particulate carrier, which could again be one or more of a gum, such as acacia gum, gum arabic, dextrin, methylcellulose gum, gelatin, soy, vegetable protein, legume seed protein, soy milk, soy milk powder, soy protein, caffeine, vegetable gum, cellulose, starch, sugar, glucose, and / or maltodextri ⁇ a.
- the dietary supplement that uses the CP material can be provided in a tablet form to be consumed once or several times per day.
- the dietary supplement comprises a portion of a single tablet, each serving suitable to be consumed one or three or more times a day, for example, in, before, or between foods as appropriate.
- a Pharmaceutical composition containing at least one extract of the cocoa polyphenol of the pericarp material described herein, in an amount sufficient to obtain the desired effect on a subject this composition may be a tablet, a liquid, capsules, soft capsules, paste , or pill, gum, or a drinkable solution or emulsion, a dry oral supplement, or even a wet oral supplement.
- the pharmaceutical composition may also contain carriers and excipients that are suitable for supplying the logically active compounds of cocoa, as well as other compounds of a different nature. The carrier / excipient class and its amount will depend on the nature of the cocoa extract or cocoa compounds or substance used and the desired mode of delivery and / or administration.
- cosmetic or cosmeceutical compositions can be produced from the CP material described herein.
- a topical form may be a solution, emulsion, serum, skin and / or hair cleanser, body shampoo, body scrubber, soap bar, liquid soap, shampoo foam, deodorant, skin care preparation and / or hair, foam, mus, cream, lotion, ointment, balm, bar, gel, pump spray, spray spray, and combinations thereof.
- the cosmeceutical compositions of this invention can be used in foams in personal care applications such as soap dish, shampoos, skin cleansers. oral and similar products.
- the estimation compositions in this way may also comprise cosmetically acceptable carriers to act as a diluent, dispersant or carrier of the CP ingredients or extracts.
- the carrier may be one selected to facilitate the distribution and absorption of cocoa-derived compounds when the composition is applied or administered.
- Vehicles other than or in addition to water may include emollients, solvents, humectants, thickeners, powders and liquid or solid perfumes.
- Step 1 Production of a CP paste
- Faso 2 Methods for drying the CP paste
- One or more of three methods can be used to dry the CP paste. The samples were dried using:
- Step 3 Screening and grinding dry pasta to produce cocoa pericarp flour
- the dried cocoa pericarp paste was finely ground using a Cunill luxo mill and sieved to obtain:
- Fine pericarp flour with a particle size of ⁇ 0.425 mm Fine pericarp flour with a particle size of ⁇ 0.425 mm.
- Thick pericarp flour with a particle size of> 0.425 mm.
- Example 2 Characterization of pericarp flour samples
- the CP paste has a moisture content of 87.4 ⁇ 0.56%.
- the drying process reduces the water content to 4.6-7.8% (see Table 1).
- the results indicate that when the freeze-drying methodology is used, a lower moisture content is obtained compared to drying the conventional or microwave paste.
- the moisture content of pericarp flour showed statistical differences (p ⁇ 0.05) between the three drying methods used.
- Water activity (Aw) and the pH of dry pericarp flour are important parameters related to the deterioration and degradation of the product.
- the pH values were similar between the drying methods used, resulting in a pH in the range of 5.57 - 5.7 (Table 1).
- the activity of the dried pericarp flour gua had low values in the range of 0.252 (freeze drying) to 0.543 (microwave), showing differences statistics among them (p ⁇ 0.05) (Table 1).
- the microwave drying method presented the highest humidity and values Aw, these are below the safe storage limit conditions that prevent enzymatic and microbiological deterioration, indicating that any of these three Drying methods can be used if only the conservation of CP flour is considered.
- the color evaluation of these flour samples can be conducted at room temperature using a color reader (CR-10, Konica-Minolta Sensing Inc., Osaka, Japan), the measured parameters were L * for luminosity; C * for chrominance; A * for red; B * for yellow, the total color difference ( ⁇ ) between fresh cocoa and dry pericarp flour was determined using an equation.
- ⁇ indicates the magnitude of the color difference between the fresh and dry samples.
- the color composition obtained from the three drying methods observed is presented in Table 2. Evaluation of flour color showed that the method of drying the cocoa pericarp flour used had significant effects, the main changes after drying were they give in Tone * and b * values, with an increase significant compared to the fresh pericarp sample which indicates the degradation of the original color by changing it to a more yellowish brownish color.
- the dried CP flour by means of the three different drying methods showed a large ⁇ of the fresh pericarp sample (> 20), which indicates a total color tone change, which can be seen with the naked eye. Freeze drying and as a result the greater color change of the pericarp between the drying methods.
- the color results after drying treatments are important since the color changes could affect the sensory properties of the CP flour, limiting its use as a food ingredient, and also directly related to changes in the composition of the samples separated.
- the color difference ( ⁇ ) is calculated using fresh pericarp cocoa flour (Fresh) as a reference.
- the biochemical evaluation of flour extract from CP can use the determinations of the total phenolic or flavonoid content or the antioxidant activity of the method described by Mart ⁇ nez et al. (2012) with modifications.
- 500 mg of fresh and dried CP flours were stirred at room temperature for 60 minutes with 20 ml of acetone-water-acetic acid (70: 29.5: 0.5). These samples were centrifuged at 3,500 g, 15 min at 4 ° C and the supernatants were kept at -20 ° C until use.
- Total phenolic content was determined using the Folin-Ciocalteu reaction.
- a volume of 0.3 ml of the flour extracts was poured in triplicate into test tubes, adding 2.5 milliliters of Folin-Ciocalteu reagent (diluted 1:10 double distilled water) and 2 ml of sodium bicarbonate solution (7.5% p / v).
- the tubes were shaken and mixed rapidly using a vortex shaker, covered with for film and incubated at 50 ° C for five minutes.
- the absorption at 760 nm was measured with a Genesys 10 UV spectrophotometer.
- the concentration was determined using standard gallic acid curves and the results were expressed as milligrams of gallic acid equivalents (GAE) / g dry mass (mean ⁇ SD).
- the total polyphenol (TPC) content of the CP flour samples are shown in Figure 3.
- the poly phenolic content was different (p ⁇ 0.05) between the three drying methods used. The highest concentration was found in freeze dried CP flour followed by microwave drying and the lowest by conventional oven drying. Freeze-drying probably caused the retention of the higher phenolic content since the drying method does not use heat to dry the samples, while with conventional oven drying, the oxidative and thermal declaration or interlacing of the polyphenols with pericarp structures probably increases given the long duration of heat treatment.
- the microwave drying process retained a considerable amount of phenolic compounds (a few milligrams below freeze drying) since it applies a short heating time, therefore, reducing thermal degradation.
- the total flavonoid content can be determined following the method described by Maleyki & Iemail, 2010. 1 ml of cocoa pericarp flour extract and 0.3 ml of NaNO 2 (0.5%) was added. The mixture was reacted for five minutes after addition of 0.3 ml of AIC1 3 6H2O (10%). The mixture was stirred and allowed to react for six minutes. 2 ml of 1 M NaOH was added and the total volume was adjusted to 10 ml with water. A UV spectrophotometer was used to read absorbance 510 no. TFC was calculated with a calibration curve using (-) - epicatechin and expressed as equivalents of (-) - epicatechin / g dry mass.
- Flavonoid content was different (p ⁇ 0.05) among the three drying methods used. The highest concentration was found in freeze dried cocoa pericarp flour followed by microwave drying and the lowest by conventional oven. The microwave drying process retained a considerable amount of flavonoid.
- the antioxidant activity can be determined by the radical scavenging properties of the flour samples, evaluated using the method previously reported by Brand-Williams et al, with some modifications.
- a stock solution was prepared by dissolving 24 mg of DPPH (2,2-diphenyl-l-picrylhydracil) with 100 ml of methanol and then storing at -20 ° C until necessary.
- the DPPH solution was obtained by mixing 10 ml of stock solution with 45 ml of methanol until an absorbance of 1.1 ⁇ 0.02 units at 515 nm was obtained using the spectrophotometer.
- the CP flour extracts (0.150 ml) were allowed to react with 2.85 ml of the DPPH solution for 2 h in the dark. The absorbance at 515 nm was measured using a UV-VIS spectrophotometer.
- the radical DPPH radical scan rate of the samples was calculated using the following equation:
- A_blanco is the solvency of the solvent
- Ajnuestra is the absorbance of the samples of the samples.
- the standard curve was linear between 25 and 800 uN of the antioxidant Trolox synthetic.
- the results express in ⁇ Trolox equivalent (TE) / g dry mass on average of the three replicates.
- CP flour exhibits a dose-dependent antioxidant activity according to the DPPH test (regardless of the method used to approach it) with a positive and significant correlation, freeze drying (R2-0.9786), conventional drying (R2-0.9561) and microwave drying (R2-0.99633).
- CP flour extracts 150 ⁇ were allowed to react with 2850 ⁇ of ABTS + solution for 2 h in a dark condition and then absorbency was measured at 734 nm.
- the standard curve was linear between 25 and 800 ⁇ M of synthetic antioxidant Trolox.
- the results express in uM equivalent Trolox (TE) / g dry mass.
- the results of the ABTS test are shown in Table 3.
- the drying methods generated a significant increase (p ⁇ 0.05) in the antioxidant activity with freeze drying of the CP flours that produced the highest values.
- the highest antioxidant activity may be related to a better level of extraction of the antioxidant compounds from the pericarp matrix using this method.
- Example 3 Clinical eight week clinical regimen using human subjects.
- a placebo-controlled clinical trial can be used to use a baked biscuit food product to demonstrate the beneficial effects of pericarp meal consumed by humans and animals.
- Several clinical endpoints can be considered, including: body weight; body mass index (BHI); abdominal circumference; body fat; muscle mass; blood triglycerides ( ⁇ ); Blood glucose; blood cholesterol; LDL cholesterol in blood; HDL cholesterol in blood; TG / HDL ratio; LDL / HDL ratio; and clamping force of the left hand.
- Subjects were recruited under the following criteria: Men and women aged 20 to 60 years; BMI of> 25 kg / m 1 at ⁇ 29.9 kg / m a ; blood triglycerides 150 - 350 mg / dL. Subjects excluded by any of the following: type 2 diabetes mellitus; dyslipidemia; hypertension; cardiovascular diseases; subjects treated with hypolipidemic drugs, metformin or steroids; pregnancy or surgery in the last six months; lupus; arthritis; hypothyroidism; HIV or anti-retroviralee treatment; consumers of alcohol or tobacco; and a history of allergy to chocolate or cocoa components.
- the placebo group received control biscuits ( ⁇ 4 g and 14 Kcal) twice a day, once in the morning and joining in the afternoon, before meals.
- Subjects in the experimental group received cookies supplemented with CP flour ( ⁇ 4 g and 14 Kcal) containing 12.5 mg of total flavonoids measured in equivalents of (-) -epicatechin, twice a day, once in the morning and once in the afternoon , before food. Subjects, scientists and clinical laboratory technicians did not have access to treatment groups.
- the holding force of the left hand can be evaluated before and after placebo treatment or with cookies containing CP flour with a dynamometer (Camry Grip Strength Dynamometer, City of Industry, CA). Subjects were instructed to apply as much force as they could. The bow was repeated three times (30 seconds between tests), the highest value was recorded. Differences at the beginning and at the end of the study (eight weeks) were compared in both groups.
- the following pertains to the manufacture and use of topical cream using cocoa pericarp flour
- control cream control cream
- CP cream CP flour
Landscapes
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Le péricarpe de la cabosse de cacao (CP) est utilisé pour produire un ingrédient alimentaire, une farine, au moyen des procédés à chaleur convective ou sèche par congélation et/ou séchage par micro-ondes. Les propriétés physiques et technologiques observées du péricarpe de la cabosse de cacao (CP) sec dévoilent son application possible en tant qu'ingrédient dans des produits alimentaires manufacturés. Les niveaux de composés bioactifs augementent significativement dans les échantillons du péricarpe de la cabosse de cacao (CP) sec en comparaison avec des matières premières, notamment dans le cas des procédés de séchage par congélation. L'utilisation commercialement avantageuse de la matière résiduelle de la cabosse de cacao peut s'appliquer dans des traitements destinés aux humains et animaux afin d'améliorer les mesures antropométriques ou les marqueurs cardiométaboliques du sang et d'améliorer la composition et la masse du corps. Les modalités de traitement des humains et animaux comprennent l'administration orale pour diminuer la proportion de LDL/HDL ou la proportion de triglycérides/HDL ou l'administration aussi bien topique que cosmétique pour traiter des lignes minces, des rides, la décoloration cutanée et d'autres affections cutanées.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3091105A CA3091105A1 (fr) | 2017-02-13 | 2018-02-13 | Compositions de pericarpe de cacao et procede de production de celles-ci |
US16/538,659 US20190357560A1 (en) | 2017-02-13 | 2019-08-12 | Compositions from cacao pericarp and methods of producing and using them |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762458408P | 2017-02-13 | 2017-02-13 | |
US62/458,408 | 2017-02-13 | ||
MXUS62/458,408 | 2017-02-13 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/538,659 Continuation-In-Part US20190357560A1 (en) | 2017-02-13 | 2019-08-12 | Compositions from cacao pericarp and methods of producing and using them |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2018147718A2 true WO2018147718A2 (fr) | 2018-08-16 |
WO2018147718A3 WO2018147718A3 (fr) | 2019-03-14 |
WO2018147718A8 WO2018147718A8 (fr) | 2019-09-26 |
Family
ID=63107692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MX2018/000012 WO2018147718A2 (fr) | 2017-02-13 | 2018-02-13 | Compositions de péricarpe de cacao et procédé de production de celles-ci |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA3091105A1 (fr) |
WO (1) | WO2018147718A2 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1027210B1 (nl) * | 2019-09-20 | 2020-11-17 | Cabosse Naturals Nv | Cacaopeulschilpoeder, werkwijze voor de bereiding en het gebruik in voedings-, farmaceutische en cosmetische samenstellingen |
BE1027209B1 (nl) * | 2019-09-20 | 2020-11-17 | Cabosse Naturals Nv | Proces om componenten van cacaopeulschillen en cacaoplacenta te extraheren, en om daarvan verkregen cacaovrucht-oplosbaar extract te gebruiken en zijn toepassingen |
BE1027685B1 (nl) * | 2020-04-17 | 2021-05-11 | Puratos | Voedingssamenstelling omvattende het omhulsel van cacaobonen |
BE1027918B1 (nl) * | 2020-11-16 | 2021-07-16 | Puratos | Voedingssamenstelling omvattende het omhulsel van cacaobonen |
WO2022031596A1 (fr) * | 2020-08-04 | 2022-02-10 | Intercontinental Great Brands Llc | Produits comestibles |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1856981B1 (fr) * | 2005-02-21 | 2010-06-02 | Si O Si Alimentos, S.A. de C.V. | Procede d'obtention d'avocat en poudre |
-
2018
- 2018-02-13 WO PCT/MX2018/000012 patent/WO2018147718A2/fr active Application Filing
- 2018-02-13 CA CA3091105A patent/CA3091105A1/fr active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1027210B1 (nl) * | 2019-09-20 | 2020-11-17 | Cabosse Naturals Nv | Cacaopeulschilpoeder, werkwijze voor de bereiding en het gebruik in voedings-, farmaceutische en cosmetische samenstellingen |
BE1027209B1 (nl) * | 2019-09-20 | 2020-11-17 | Cabosse Naturals Nv | Proces om componenten van cacaopeulschillen en cacaoplacenta te extraheren, en om daarvan verkregen cacaovrucht-oplosbaar extract te gebruiken en zijn toepassingen |
BE1027685B1 (nl) * | 2020-04-17 | 2021-05-11 | Puratos | Voedingssamenstelling omvattende het omhulsel van cacaobonen |
WO2021209609A1 (fr) * | 2020-04-17 | 2021-10-21 | Puratos | Compositions alimentaires comprenant de la coque de cabosse |
CN115426899A (zh) * | 2020-04-17 | 2022-12-02 | 普拉托斯有限公司 | 包含可可豆荚壳的食品组合物 |
WO2022031596A1 (fr) * | 2020-08-04 | 2022-02-10 | Intercontinental Great Brands Llc | Produits comestibles |
CN115802906A (zh) * | 2020-08-04 | 2023-03-14 | 洲际大品牌有限责任公司 | 可食用产品 |
BE1027918B1 (nl) * | 2020-11-16 | 2021-07-16 | Puratos | Voedingssamenstelling omvattende het omhulsel van cacaobonen |
Also Published As
Publication number | Publication date |
---|---|
CA3091105A1 (fr) | 2018-08-16 |
WO2018147718A3 (fr) | 2019-03-14 |
WO2018147718A8 (fr) | 2019-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018147718A2 (fr) | Compositions de péricarpe de cacao et procédé de production de celles-ci | |
US20060233738A1 (en) | Composition for promoting production of type 1 collagen and/or elastin | |
JP2009263275A (ja) | 抗酸化剤並びにそれを含有する化粧料、飲食品組成物及び医薬品組成物 | |
US20110060039A1 (en) | Composition | |
JP2002293736A (ja) | メーラード反応阻害剤およびそれを含有する組成物 | |
KR101474998B1 (ko) | 피부 주름 생성 억제 및 주름 개선 활성을 갖는 백차 추출물을 함유하는 조성물 | |
JP2007269659A (ja) | 抗酸化組成物 | |
JP2011055837A (ja) | 美容用飲食品 | |
US20190357560A1 (en) | Compositions from cacao pericarp and methods of producing and using them | |
KR20150143106A (ko) | 혼합 생약재 추출물을 유효성분으로 포함하는 노화방지, 피부미백용 조성물 | |
EP2062588A1 (fr) | Composition pour l'amélioration de l'état de la peau | |
JP2003137801A (ja) | コラーゲン産生促進剤、コラゲナーゼ阻害剤、線維芽細胞増殖作用剤及び皮膚化粧料並びに美容用飲食品 | |
KR101447007B1 (ko) | 디프테로카퍼스 옵터시포리어스 추출물을 유효성분으로 함유하는 노화방지용 조성물 | |
JP4705608B2 (ja) | 食品組成物 | |
ES2217966B1 (es) | Productos alimenticios que comprenden un extracto de hollejo, semillas y raspas de uva. | |
CN1938039A (zh) | 皮肤保湿功能改善剂 | |
JP2011184358A (ja) | 経口摂取用皮膚内透明度増加剤 | |
JP6757995B2 (ja) | 経口組成物 | |
JP5665117B2 (ja) | 抗酸化剤、化粧料、飲食品組成物及び医薬品組成物 | |
KR101806220B1 (ko) | 상추꽃 추출물 또는 분획물을 유효성분으로 함유하는 항산화 또는 항노화용 조성물 | |
KR101410262B1 (ko) | 미백 화장료 조성물 | |
KR101461704B1 (ko) | 모로우붉은실 추출물을 유효성분으로 포함하는 자외선에 의한 피부손상 억제 및 피부치료용 조성물 | |
JP7262319B2 (ja) | メラニン生成抑制剤、及びメラニン生成抑制剤の製造方法 | |
KR101354552B1 (ko) | 데카스퍼뮴 프루티코숨 추출물을 유효성분으로 함유하는 노화방지용 조성물 | |
KR20230126758A (ko) | 항산화 활성이 향상된 복합추출물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18751363 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18751363 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 3091105 Country of ref document: CA |